RNA interference: mechanisms, technical challenges, and therapeutic opportunities.
1Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310, Oslo, Norway, Mouldy.Sioud@rr-research.no.
Methods in Molecular Biology (Clifton, N.J.)
|October 17, 2014
Summary
RNA interference (RNAi) offers therapeutic potential for diseases like infections and cancers. Advances in small interfering RNA (siRNA) design and delivery strategies are enhancing its clinical applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Therapeutics
Background:
- RNA interference (RNAi) is a powerful mechanism for inhibiting gene expression.
- Therapeutic applications of RNAi are being explored for various diseases, including infections and cancers.
- Significant progress has been made in understanding RNAi mechanisms.
Purpose of the Study:
- To review recent advances in the design of small interfering RNAs (siRNAs).
- To discuss novel developments in siRNA delivery strategies.
- To provide insights for optimizing therapeutic siRNA design and delivery.
Main Methods:
- Literature review of recent research in RNAi therapeutics.
- Analysis of advancements in siRNA design principles.
- Evaluation of emerging siRNA delivery technologies.
Main Results:
- Improved understanding of RNAi mechanisms has led to more potent and specific siRNA designs.
- New delivery strategies are enabling preclinical and clinical translation of siRNA-based therapies.
- Key insights into optimizing siRNA efficacy and safety have been identified.
Conclusions:
- Therapeutic siRNA design has advanced significantly, enhancing potency and specificity.
- Innovative delivery methods are crucial for successful clinical translation of RNAi.
- This review offers guidance for future development of RNAi-based therapeutics.
More Related Videos
Related Concept Videos
RNA Interference
6.4K
6.4K
RNA Interference
24.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Nucleotide Excision Repair
4.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.5K
Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K


